Valeo Financial Advisors, LLC Emergent Bio Solutions Inc. Transaction History

Valeo Financial Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 12, 2021	SELL	$86.23 - $125.19 $4,311 - $6,259	-50 Closed	0 $0
Q4 2020 Feb 11, 2021	SELL	$79.17 - $111.47 $19,792 - $27,867	-250 Reduced 83.33%	50 $4,000
Q3 2020 Oct 28, 2020	BUY	$81.91 - $134.94 $7,781 - $12,819	95 Added 46.34%	300 $31,000
Q2 2020 Jul 20, 2020	BUY	$54.33 - $89.52 $434 - $716	8 Added 4.06%	205 $16,000
Q4 2019 Jan 24, 2020	SELL	$51.21 - $59.06 $307 - $354	-6 Reduced 2.96%	197 $11,000
Q3 2019 Oct 15, 2019	BUY	$40.6 - $57.2 $162 - $228	4 Added 2.01%	203 $11,000
Q2 2019 Jul 10, 2019	BUY	$39.92 - $53.86 $6,307 - $8,509	158 Added 385.37%	199 $10,000
Q3 2018 Nov 01, 2018	BUY	$52.05 - $66.51 $2,134 - $2,726	41 New	41 $3,000

174

36.8M

336K

203K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $285M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.